1. Introduction {#sec1}
===============

The outbreak of COVID-19, caused by the Noval Corona Virus (nCoV) that is now officially designated as Severe Acute Respiratory Syndrome-Related Coronavirus SARS-CoV-2, represents a pandemic threat to global public health. Although the epicentre of the Covid -19 outbreak in December of 2019 was located in Wuhan China, this disease has spread to more than 200 countries with over 3000 000 confirmed cases and still continuing.

Ayurveda is a life science having a holistic approach in dealing with different types of diseases. It has a completely different way of looking at any new diseases. Understanding of any disease in Ayurveda is done by five elements, i.e. *Hetu, Purvarupa, Rupa, Upashaya-Anupashaya, Samprapti*. \[[@bib1]\] By these elements we get to know about the nature of the diseases *(Vikara Prakruti)*, site of the diseases *(Adhisthanam)*, the course of the disease *(Samprapti)* and about the aggravating factors of the disease. By understanding these factors in detail, we can design the preventive measures and treatment protocol for the disease. Though Ayurveda focuses on the concept of individualism and accepts that each individual is unique but in this situation of the pandemic when many people are affected by the same set of symptoms, we can briefly design a treatment policy by considering the available information about the disease.

Thus, it is the need of an hour to think out of the box so here is an initiation to think about the disease through Ayurveda perspective. The main objective of this study is to look over the disease through Ayurvedic perspective, analyse possible pathologies, select appropriate drugs and to study in-silico screening on these selected drugs. Though, there are many protease of the disease present but this study is limited to virtual screening against main protease (Mpro) of the virus. The present piece of work studies the virtual screening of the phytoconstituents which can help for a further *invitro, invivo* research for Covid 19.

According to WHO, People who have co-morbidities and those over 60 years of age have a higher risk of developing severe symptoms of Covid 19. \[[@bib2]\] Common symptoms of Covid 19 include fever *(Jwar),*tiredness *(Shrama, Klama) and* dry cough*(Shushka Kasa)*. Other symptoms include shortness of breath *(Shwasa),* aches and pains *(Anga Mardam*), sore throat *(Kantha Shoola),* very few people will report diarrhoea (*Drava Mala)*, nausea *(Hrullas)* or a runny nose *(Peenasa).*

1.1. Possible Ayurvedic Concepts {#sec1.1}
--------------------------------

With the help of the available data regarding Covid19 and after going through the Ayurveda classics thoroughly, the following possible pathological models can be drawn.

### 1.1.1. Janapada-Udhwamsa Vikara \[[@bib3]\]. {#sec1.1.1}

Covid-19 has evolved itself into a pandemic, affecting a large population irrespective of their physical features, dietary patterns, psychological attributes, etc., Ayurveda considers it as a *Janapada-Udhwamsa Vikara.*

### 1.1.2. Vaata Kafaja Jwara \[[@bib4]\]. {#sec1.1.2}

By looking at its symptomatology, it resembles with the classical features of *Vaata Kafaja Jwaram* mentioned in the classics.

### 1.1.3. Bhuutabhishangajam Jwara \[[@bib5]\]. {#sec1.1.3}

It can also be grouped under the class of *Aagantuja Vikaara* with special reference to the class of *Bhuutabhishangajam Jwara.* The management of *Aagantuja Vikaara* should follow the lines of *Nija Vikaara.*

### 1.1.4. Aupsargika Jwara \[[@bib6]\]. {#sec1.1.4}

Covid 19 is transmitting from one human to others by direct contact *(Gatra Sansparshat)*, air droplet *(Ni-shwaasat)*. This type of the disease is termed as *Aupsargika* in Ayurveda.

### 1.1.5. Dhatu Paka Awastha \[[@bib7]\]. {#sec1.1.5}

Few severe conditions show symptoms of *Sannipata Jwar* leading to *Dhatupaka Awsatha* where all three *Doshas* get vitiated and suppress the *Dhatu Bala* (immunity) of an individual leading to *Oja-Kshaya* and ultimately Death.

1.2. Etiology of disease in Ayurveda terms {#sec1.2}
------------------------------------------

*Dosha -- Vaata, Kapha PradhanaDushya- Rasa, Rakta, Mansa, OjaAdhisthana- Koshtha (Aamashaya* **and** *Ura Pradesha)Strotas- Pranavaha Strotas, Annavaha StrotasAwastha-* **Stage 1** *: Vaat Kaphaj Jwara***Stage 2** *: Vaat Kafaj Sannipatik Jwara***Stage 3** *: Sannipatik Jwara, Dhatupaka Awastha.Upashaya- Pravar Bala- Uttam UpashayaAnupashaya: Vrudha Vaya -- Anupashaya.*

2. Material and methods {#sec2}
=======================

2.1. Proteins/Macromolecules {#sec2.1}
----------------------------

Covid -19 3clpro/Mpro (PDB ID: 6LU7) structures was obtained from PDB in.pdb format. PDB is an archive for the crystal structures of biological macromolecules, worldwide. The 6LU7 protein contains two chains, A and B, which form a homodimer. Chain A was used for macromolecule preparation.\[[@bib8]\] The coronavirus main protease (Mpro), which plays a pivotal role in viral gene expression and replication through the proteolytic processing of replicase polyproteins, is an attractive target for anti CoV drug design.\[[@bib9]\].

2.2. Ligand and Drug Scan {#sec2.2}
-------------------------

The 160 3-dimensional (3D) structures were obtained from PubChem in.sdf format. PubChem is a chemical substance and biological activities repository consisting of three databases, including substance, compound, and bioassay databases. The compounds used in the present study is shown in [table no.2](#tbl2){ref-type="table"} , along with its binding energy with protein. \[[@bib10]\].Table 1Ayurvedic properties of following drugs \[[@bib18]\]Table 1Sr no.Drug nameLatin nameFamilyRasaGunaViryaDoshaghnataKarma1*SunthiZingiber officinale* Roscoe*ZingiberaceaeKatuSnigdha, TeekshnaUshnaVaatkaphapahamDeepana, Rochana, Shoolprashamana*2*PushkarmoolaInula racemose* Hook.F.*AsteraceaeKatu TiktaLaghuUshnaVaatkaphaShwasahara, Parshwashool Nut, Jwarghna, Shwaas*3*GuduchiTinospra cordifolia* Miers*MenispermaceaeTikta, KatuLaghu, Snighdha,UshnaDoshatraya-Hara,Jwaraghna, Rasayan, Kaas, Pandu.*4*KantakariSolanum zanthocarpum* L.*SolanaceaeKatu TiktaDeepana, Laghu, Sara, Ruksha,UshnaKapha-vaatghnaShwaas --Kaas Jit, Pachani, Parshwa-Amayan*5*PippaliPiper longum* L.*PiperaceaeKatuDeepana, Snighdha, LaghuAnushnaVaat-ShleshmahariVrushya, Rasayana, Shwaas-Kaas Hara*6*HaridraCurcuma longa* L.*ZingibraceaeKatu, TiktaRukshaUshnaPrameha-Hara, Kapha-Pittanut*7*ShatavariAsparagys racemosus* Willd.*LiliaceaeTikta, MadhuraSnighdha, GuruSheetaVaat-PittaghnaRasayani, Balya,*8*GokshuraTribulus terrestris* L.*ZygophyllaceaeMadhuraSnighdha, GuruSheetaVaat-NutBalya, Basti-Shodhana, Vrushya, Shwaas-Kaas-Ghna*9*YashtimadhuGlycyrrhiza glabra* L.*FabaceaeMadhuSnighdha, GuruSheetaPitta-Vaat-Ghna.Balya, Shukral*10*MustaCyperus rotundus* L.*CyperaceaeKatu, Tikta, KashayaLaghu, Ruksha.SheetaKapha-Pitta Hrut,Deepana- Pachana, Grahi, Jwaraghna*Table 2Properties of Covid -19 M^pro^ potential inhibitor candidates.Table 2Sr No.Chemical constituentBinding energyInhibitionLipinski ruleTarget Prediction1Hydroxychloroquine-3.85 kcal/mol1.50 mMMolecular weight335.87Tyrosine-protein kinase SYK\#H-bond acceptors3Tyrosine-protein kinase LCK\#H-bond donors2Macrophage colony stimulating factor receptoriLOGP3.58Lipinski \#violations02Quinine-5.62 kcal/mol0.0761 mMMolecular weight324.42Tyrosine-protein kinase ABL\#H-bond acceptors4Tyrosine-protein kinase LCK\#H-bond donors1Tyrosine-protein kinase SYKiLOGP3.36Macrophage stimulating protein receptorLipinski \#violations0***Sunthi* (*Zingiber officinale* Roscoe*)***36gingesulphonic acid-6.20 kcal/mol5.36 mMMolecular weight358.45Interferon-induced, double-stranded RNA-activated protein kinase\#H-bond acceptors6Angiotensin converting enzyme\#H-bond donors2Tyrosine-protein kinase LCK-iLOGP2.48Tyrosine-protein kinase HCKLipinski \#violations0***Pushkarmool* (*Inula racemose* Hook.F.*)***4Alantolactum-6.70 kcal/mol0.01540 mMMolecular weight232.32Inhibitor of nuclear factor kappa B kinase beta subunit\#H-bond acceptors2T-cell protein-tyrosine phosphatase p\#H-bond donors0Protein-tyrosine phosphatase 1BiLOGP2.75Lipinski \#violations0***Guduchi* (*Tinospora cordifolia* Miers)**5Berberine-7.00 kcal/mol0.01757 mMMolecular weight336.36Inhibitor of nuclear factor kappa B kinase beta subunit\#H-bond acceptors0\#H-bond donors0iLOGP0Lipinski \#violations0***Kantakari* (*Solanum xanthocarpum* L.*)***6Stigmasterol-6.90 kcal/mol0.01083 mMMolecular weight412.69Angiotensin converting enzyme\#H-bond acceptors1Indoleamine 2,3dioxygenase\#H-bond donors1Protein-tyrosine phosphatase 1BiLOGP4.76Lipinski \#violations1***Pippali* (*Piper longum* L.*)***7Bisdemethoxycurcumin-6.90 kcal/mol0.10335 mMMolecular weight308.33Glycogen synthase kinase-3 beta\#H-bond acceptors4Inhibitor of NFkappa-B kinase (IKK)\#H-bond donors2Macrophage colony stimulating factor receptoriLOGP1.75Lipinski \#violations0***Haridra* (*Curcuma longa* L.*)***8Demethoxycurcumin-6.20 kcal/mol0.188.74 mMMolecular weight338.35Inhibitor of NFkappa-B kinase (IKK)\#H-bond acceptors5Toll-like receptor (TLR7/TLR9)\#H-bond donors2Tyrosine-protein kinase LyniLOGP2.78Tyrosine-protein kinase BTKLipinski \#violations0***Shatavari (Asparagus racemosus* Willd*)***9Kaempferol-6.70 kcal/mol0.06181 mMMolecular weight286.24Tyrosine-protein kinase SRC\#H-bond acceptors6Tyrosine-protein kinase receptor UFO\#H-bond donors4Interleukin-8 receptor AiLOGP1.7Lipinski \#violations0***Gokshura* (*Tribulus terrestris* L.*)***10Gitogenin-8.00 kcal/mol0.00366 mMMolecular weight432.64Tyrosine-protein kinase JAK3\#H-bond acceptors4Nuclear receptor ROR-gamma\#H-bond donors2iLOGP4.19Lipinski \#violations1***Yashtimadhu* (*Glycyrriza Glabra* L.)**11Glycerol-8.47 kcal/mol0.00062273 mMMolecular weight92.09Glycogen synthase kinase-3 beta\#H-bond acceptors3Tyrosine-protein kinase ABL\#H-bond donors3Tyrosine-protein kinase JAK1iLOGP0.45Tyrosine-protein kinase JAK3Lipinski \#violations0Tyrosine-protein kinase LCK***Musta* (*Cyprus Rotundus* L.)**12Patcholane-6.12 kcal/mol0.03258 mMMolecular weight206.37Interleukin-6 receptor subunit beta\#H-bond acceptors0Tyrosine-protein kinase JAK1\#H-bond donors0Tyrosine-protein kinase JAK2iLOGP3.22Tyrosine-protein kinase JAK3Lipinski \#violations1Tyrosine-protein kinase TYK2

2.3. Molecular Docking {#sec2.3}
----------------------

The Ligand was docked against the protein and the interactions were analyzed by using by Pyrx 0.8. For the docking of ligands into protein active site and to estimate the binding affinities of docked compounds and for generation of grid, studies were carried out using pyrx AutoDock wizard with MGL tools 1.5.6 installed in a Pentium ®Dual --Core CPU T4200 machine running on a 2.0 GHz Intel Core processor with 2GB RAM by using Lamarkian Algorithm. The scoring function gives score based on best docked ligand complex is picked out. \[[@bib11]\].

2.4. Swiss ADME {#sec2.4}
---------------

Drug-like properties were calculated using Lipinski's rule of five, which proposes that molecules with poor permeation and oral absorption have molecular weights \> 500, C logP \> 5, more than 5 hydrogen-bond donors, and more than 10 acceptor groups. Adherence with Lipinski's rule of five as calculated using SWISS ADME prediction. \[[@bib12]\], \[[@bib13]\], \[[@bib14]\].

2.5. Swiss Target Prediction {#sec2.5}
----------------------------

The active site of a protein was determined using the Swiss Target Prediction. The unique engine behind swiss target prediction, extensively detailed elsewhere, calculate the similarity between the users query compound and those compiled in curated, cleansed collection of known actives in well defined experimental binding assays. The quantification of similarity is 2 folds. It gives the active site bind to the molecule. \[[@bib15]\] \[[@bib16]\].

3. Results and Discussion {#sec3}
=========================

Within weeks from when the genetic sequence of the SARS-CoV-2 was made available, structural biologists have used these techniques to see proteins that make up the SARS-CoV-2 virus. In this study, as shown in the [table no.1](#tbl1){ref-type="table"}, we have selected 10 drugs on the basis of their ayurvedic properties which can probably be used for SARS-CoV-2. For every plant we carried out molecular docking on each phytoconstituent present in the plant. From this, we selected one phytoconstituent from every plant which is having higher binding energy and inhibition to protein molecule of SARS-CoV-2. The protein molecule used for the study is 6lu7. As hydroxychloroquine and quinine are being used at present for the treatment of Covid 19. \[[@bib17]\] Thus we are comparing the efficacy of the following drugs with the hydroxychloroquine and quinine. The molecular docking, Lipinski Rule of Five and Target prediction were calculated. Target prediction for SARS-CoV-2, Humoral immunity and Antiviral activity were taken and searched on the selected phytoconstituents. The data is shown in [table no.2](#tbl2){ref-type="table"}. Grid of the phytoconcstituents is shown in [Figure 1](#fig1){ref-type="fig"} .Figure 1Visulaisation of selected phytoconstituents through pyrx. A represents visualisation of Hydroxychloroquine with protein 6lu7. B represents visualisation of Quinine with protein 6lu7. C represents visualisation of *Sunthi* (*Zingiber officinale* Roscoe*)* with protein 6lu7. D represents visualisation of *Pushkarmool* (*Inula racemose* Hook.F.*)* with protein 6lu7. E represents visualisation of *Guduchi* (*Tinospora cordifolia* Miers) with protein 6lu7. F represents visualisation of *Kantakari* (*Solanum xanthocarpum* L.*)* with protein 6lu7. G represents visualisation of *Pippali* (*Piper longum* L.*)* with protein 6lu7. H represents visualisation of *Haridra* (*Curcuma longa* L.*)* with protein 6lu7. I represents visualisation of *Shatavari (Asparagus racemosus* Willd*)* with protein 6lu7. J represents visualisation of *Gokshura* (*Tribulus terrestris* L.*)* with protein 6lu7. K represents visualisation of *Yashtimadhu* (*Glycyrriza Glabra* L.) with protein 6lu7. L represents visualisation of *Musta* (*Cyprus Rotundus* L.) with protein 6lu7.Figure 1

From studying the patho-physiology of the disease through Ayurveda perspective we have selected 10 Ayurvedic drugs according to their properties. The molecular docking study gives tremendous results for the selected phytoconstituents. 6 gingesulphonic acid having higher binding energy and inhibition constant than hydroxychloroquine and quinine. Other phytoconstituents having less binding energy and inhibition constant than 6 gingesulphonic acid. Hydroxychloroquine and quinine are also having less binding energy and inhibition constant than 6 gingesulphonic acid which is present in *Sunthi*. Most of the selected compound follows Lipinski Rule of Five so they are pharmacologically active compounds. Also target prediction of selected phytoconstituents were carried out in which we got the target which are effectable on SARS-COV-2, Humoral immunity and Antiviral activity.

From overviewing the Ayurvedic perspective, etiology of the disease and studying the phytoconstituents of the drugs, we hypothesized to use *Nagaradi Kashaya* which includes ***Sunthi* (** *Zingiber officinale* Roscoe*),* ***Pushkarmool*** (*Inula racemose* Hook.F.*),* ***Guduchi*** (*Tinospora cordifolia* Miers.), ***Kantakari*** (*Solanum virginianum* L.*)* for combating Covid 19.^\[19\]^ The above combination is mentioned in *Jwara Chikitsa.* As most of the drugs are having *Tikta Rasa, Laghu* and *Pachana Guna.* It helps for *Aama Pachana* in the body. It also has *Kaas*-*Shwaas-ghna* properties. It is indicated for *Jwara, Kaas, Shwaas, Parshawashoola* i.e. the symptoms similar to SARS-COV-2. Primary evidence for the usage of these drugs, virtual screening of the drugs shows positive results.

As though we use phytoconstituents for this study but further research is necessary to investigate the potential uses of the medicinal plants as a whole.

4. Limitations of the study {#sec4}
===========================

Although computer-aided drug design and network pharmacology have been widely used and developed, there still have deficiencies and limitations: (1) The model maturity and computational accuracy of computer docking algorithms need to be further improved. (2) Due to the structure-based methodology, several compounds are not suitable for computer-aided design because of their special structure characteristics. (3) A large number of databases can improve different information for the obtained potential targets, the progress of the selection of these databases and their effective information annotation, still requires continuously practical activities to optimize. With the advancement of computer science, and the constant optimization of algorithms, including the maturity of the protein model. Through more practical researches and development examples to upgrade the entire process of in silico methodology, we believe that in the future, this methodological process will enable the discovery of new drugs more efficiently, accurately and quickly. This methodology will be more widely usable in future work on revealing and predicting the basis of medicinal materials.

5. Conclusion {#sec5}
=============

Currently, Covid -19 has emerged in the human population and is a potential threat to global health worldwide. Many drug research and developments projects as well as vaccine development research work is in progress. The aim of this study is to examine several medicinal plant-derived compounds that may be used to inhibit the Covid -19 infection pathway.

Thus, from the above results obtained from reviewing Ayurveda classics and after the virtual screening of selected drugs we can conclude that *Nagaraadi Kashaya* may have appreciable results in combating SARS-COV-2. *Nagaraadi Kashaya* can be a trial candidate for conducting further clinical trial.
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